Despite its underutilization, AI-powered diabetic retinopathy screening was associated with greater OCT referral rates than traditional screening methods. Artificial intelligence (AI)-based diabetic ...

Optain Health, a startup that built artificial-intelligence-powered retinal screening technology, acquired EyePACS to add its teleophthalmology network and expand access to eye disease screening in ...

Please provide your email address to receive an email when new articles are posted on . AEYE Health has received the first-ever FDA clearance for a fully autonomous AI that can diagnose referable ...

Diabetes is a chronic condition that affects millions worldwide, often silently impacting vital organs over time. One of the most serious yet preventable complications of diabetes is diabetic ...

Recent reports suggest diabetic retinopathy is more common in younger people than previously thought, leading to a call for more frequent screening for this condition and more attention to follow-up ...

India has launched its first AI-driven diabetic retinopathy programme to address blindness in diabetic patients. It is an ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Diabetic retinopathy, a leading cause of vision loss affecting millions, damages the retina's blood vessels. Experts highlight late detection due to i ...

APOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic ...

Retinal tear surgery and retinal detachment surgery are distinct medical procedures. The retina is a thin layer of light-sensitive tissue at the back of your eyes. Your eye lens focuses light onto ...